𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers

✍ Scribed by Yoshihito Yokoyama; Bing Xin; Tatsuhiko Shigeto; Hideki Mizunuma

Publisher
Springer-Verlag
Year
2011
Tongue
English
Weight
584 KB
Volume
137
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Inhibitory effect of meloxicam, a select
Inhibitory effect of meloxicam, a selective cyclooxygenase-2 inhibitor, and ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, on the growth of human ovarian cancers
✍ Bing Xin; Yoshihito Yokoyama; Tatsuhiko Shigeto; Masayuki Futagami; Hideki Mizun 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 308 KB

## Abstract ## BACKGROUND. It was recently reported that high expression of peroxisome proliferator‐activated receptor γ (PPARγ) and low expression of cyclooxygenase‐2 (COX‐2) might be involved in the inhibition of ovarian tumor progression and confirmed that PPARγ activation could suppress COX‐2

Ligands for peroxisome proliferator-acti
Ligands for peroxisome proliferator-activated receptor γ inhibit growth of pancreatic cancers both in vitro and in vivo
✍ Atsushi Itami; Go Watanabe; Yutaka Shimada; Yosuke Hashimoto; Junichiro Kawamura 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 634 KB

Peroxisome proliferator-activated receptor ␥ (PPAR␥) is expressed largely in adipose tissues and plays an important role in adipocyte differentiation. Several studies have recently shown that ligands of PPAR␥ could lead to growth inhibition in some malignancies. In our study, we focused on pancreati

Expression of peroxisome-proliferator ac
Expression of peroxisome-proliferator activated receptor-gamma (PPARγ) and the PPARγ co-activator, PGC-1, in human breast cancer correlates with clinical outcomes
✍ Wen G. Jiang; Anthony Douglas-Jones; Robert E. Mansel 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 1 views

## Abstract Peroxisome‐proliferator activated receptor‐gamma (PPARγ) belongs to a family of nuclear receptors and acts as receptor for peroxisome‐proliferators, steroids, retinoic acids, and polyunsaturated fatty acids. Our study examined the transcript levels of peroxisome‐proliferator activated r

A recombinant humanized anti-insulin-lik
A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts
✍ Liliane Goetsch; Alexandra Gonzalez; Olivier Leger; Alain Beck; Petrus J. Pauwel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 959 KB

## Abstract Interaction of insulin‐like growth factor receptor I (IGF‐IR) with its ligands has been reported to induce cell proliferation, transformation and blockade of cell apoptotic functions. IGF‐IR is overexpressed on numerous tumor cell types and its blockade could be of importance for anti‐c